 SEATTLE, WA and VANCOUVER, BC ACCESSWIRE June 3, 2021 Achieve Life Sciences, Inc. NASDAQ:ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application No. 16993,522 the 522 Application and U.S. Patent Application No. 